Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.

New data suggest that lenacapavir delivered just once per year could be as effective for HIV prevention as the twice-yearly ...

HIV/AIDS continues to disproportionately affect Black Americans, despite overall progress in reducing infection rates.

Like most prescribed medications, all three brands PrEP brands feature side effects. Here's how to prepare for them.

Baystate Wing Hospital in Palmer, Mass., has contacted an unknown number of patients who may have been exposed to hepatitis or HIV due to a potential sterilization issue during surgeries performed ...

In a ceremony held last month, the 2024 Louisa Gross Horwitz Prize was awarded to Wesley Sundquist, PhD, Leo T. and Barbara K ...

Every year, my colleagues and I put together a list of what we think are the top 10 breakthrough technologies of that year.

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

Nearly half of all new cases in 2022 were in the South. "The frustrating part is we have the tools now to stop it." ...

Gilead has reported results for a once-yearly intramuscular injection that show blood concentrations of lenacapavir exceeded ...

A patient told MassLive she was horrified to receive a phone call from her surgeon post-operation saying she should be tested for bloodborne pathogens.

A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...